Surgical Hemostat Market Synopsis
According to a new report published by Introspective Market Research, titled, “Surgical Hemostat Market by Application and Packaging Type: Global Opportunity Analysis and Industry Forecast, 2024–2032,”
The global Surgical Hemostat Market size was valued at $4.91 billion in 2023, and is projected to reach $8.95 billion by 2032, registering a CAGR of 6.9% from 2024 to 2032.
The absorbable hemostat is used as an adjunct to surgical procedures to support outflow control of capillaries, veins, and small arteries when ligation or other conservative control methods are impractical or unproductive. An innovative hemostat cut to size for endoscopic procedures.
Hemostats are designed to compress small blood vessels to control leakage. Another use is to hold and save the artificial fascia during debilitating and debilitating injuries. This device is perfect for exposing, exploring, and visualizing the deep parts of a wound. Two types of hemostats are commonly used in wound treatment. A typical hemostat is recommended. For better treatment of small wounds, it is often best to use a 5-inch curved mosquito hemostat with finely serrated jaws.
Hemostatic devices are available in many different forms that are used in many procedures. These hemostats include Bainbridge forceps, Adson forceps, Mosquito forceps, Crile forceps, Kelly forceps, etc. Surgeons choose the best according to their comfort and surgical needs, the doctor can perform successful operations. New and familiar products have been developed to manage continuous medical discharge in isolated surgical bleeds and their routine and safety profile is supported by medical studies in multiple surgical procedures. The newly announced powder formulation of the Powder products is designed to help with light to moderate bleeding in a variety of tissue envelopes, including broad or sparse surfaces and areas where contact or placement of tissue ORC products may be stimulating or impractical.
Bleeding from trauma or surgery is a serious health problem and uncontrolled bleeding can be fatal. The development of effective, safe and convenient hemostatic materials is important. Rapid and active hemostasis can reduce the possibility of trauma cells spreading with the blood. Hemostatic ingredients are the most important applications in wound care and it is also used for hemostasis during operations for malignant trauma. Operative treatment has been an important factor in health care worldwide for more than a century. Traumatic injuries, cancers and cardiovascular diseases continue to increase, and the public health impact of operative involvement is ever increasing.
In cardiac surgery, hemostasis is an important therapeutic requirement in cardiac and coronary artery surgery. The ability to close to support the suture is very much needed in vascular surgery. Flowable sutures that close by accelerating the hemostatic cascade are the standard for hemostasis and sealing area, a dual-action defence of various cardiovascular signals defined by evidence-based medicine.
Global Surgical Hemostat Market, Segmentation
The Surgical Hemostat Market is segmented based on Product Type, application, Formulation, end-users and region.
Type:
The type segment is further classified into Thrombin Based, Oxidized Regenerated Cellulose Based, Gelatine Based, Collagen Based Hemostat. Among these, the Thrombin-based sub-segment accounted for the highest market share in 2023. Achieving hemostasis is crucial in the surgical process. Clinical ligation of bleeding vessels or electrocautery of small vessels fails or is not possible, so doctors rely on thrombin. Thrombin has a number of well-studied biological effects, it helps to carry out coagulation and hemostasis, tissue damage and bleeding, revealing the activity of collagen and released tissue, stimulating the internal and external coagulation pathways. Thrombin can be determined directly on several cell types. Smooth muscle cells cause blood vessels to constrict and contribute to hemostasis. Activation of platelets promotes their combination at the site of thrombus formation. Activated thrombin also becomes a mitogen and chemoattractant for neutrophils and fibroblasts and continuously induces the formation of vascular endothelial growth factor for tissue and blood vessel regeneration and repair.
Formulation:
The Formulation segment is further classified into Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats. Among these, the personal care sub-segment is anticipated to show the fastest growth by 2032. A sponge is a therapeutic device intended for use as a hemostatic agent at the sites of bleeding. The sponge is a water-insoluble, off-white, non-elastic, porous, elastic product made from purified pig skin, gelatin USP granules, and water for injections (USP). It can absorb and store several times its weight in blood and other fluids. The physical surface modification of the gelatin sponge results in a rapidly absorbing hemostat that forms a better bond and hemostasis compared to other developed hemostats.
Gelatin sponges are inexpensive to manufacture, contain no blood-derived ingredients, are safely absorbed into the body, and are effective hemostats. it is used as a topical dressing under the supervision of a healthcare professional on moderately to heavily bleeding wounds such as surgical wounds (post-operative, donor wounds, dermatological wounds), cuts and minor wounds. bleeding from local ENT surgical wounds and epistaxis. It is also indicated for the control of skin bleeding at percutaneous needle, vascular access, and percutaneous catheter entrances.
Region:
The United States has thousands of hospitals and health centers in all 50 states. Although many of these hospitals specialize in certain types of treatment, most perform certain types of surgery on a daily basis. For example, the US hospital that performed the most surgeries in 2023 is Ochsner LSU Health Shreveport - St Mary's Medical Center in Shreveport, Louisiana. This facility is a leading academic medical center affiliated with Louisiana State University and performed approximately 236,873 operations in 2023. The number of ambulatory care centers in the United States has increased in recent years. This was partially reversed by advances in medical technology that made many surgeries less invasive, allowing them to be performed on an outpatient basis.
Some of The Leading/Active Market Players Are-
- Becton, Dickinson and Company (US)
- Medtronic plc (US)
- Teleflex Corporation (US)
- Baxter International Inc. (US)
- B. Braun Melsungen AG (Germany)
- Stryker Corporation (US)
- CuraMedical BV (Netherlands)
- Gelita Medical GmbH (Germany)
- Integra LifeSciences (US)
- Marine Polymer Technologies, Inc. (US) and Other Active Players
Key Industry Developments
- In November 2023, Ethicon announced CE mark approval for its adjunctive hemostat solution ETHIZIA. ETHIZIA Hemostatic Sealing Patch is used for disrupting bleeding on internal organs, except neurological and cardiovascular. This helped company to strengthen its product portfolio.
- In August 2023, the Teleflex Corporation received U.S. FDA clearance for its QuikClot Control+ Hemostatic Device. This device helps surgeons to control bleeding during cardiac surgical procedures. Therefore, approval of this product helped the company to enhance its product offerings.
Key Findings of the Study
- Thrombin-based hemostats accounted for the highest market share in 2023, highlighting their crucial role in achieving hemostasis when conventional methods like ligation or electrocautery are not feasible.
- Gelatin-based sponge hemostats are anticipated to show the fastest growth by 2032, driven by their effectiveness in absorbing and storing blood and other fluids, making them suitable for various bleeding wound applications.
- The United States, with its extensive network of hospitals and healthcare centers, plays a significant role in the Surgical Hemostat Market, with notable facilities like Ochsner LSU Health Shreveport - St Mary's Medical Center performing a substantial number of surgeries annually.
